<DOC>
	<DOCNO>NCT00095537</DOCNO>
	<brief_summary>The purpose trial identify high oral dose BMS-599626 , drug direct EGFR HER2 proteins , give safely daily schedule 21 day 7 day rest period patient cancer longer benefit commonly used treatment . The study also test protein may affect BMS-599626 ; level study drug blood study .</brief_summary>
	<brief_title>BMS-599626 Patients With Advanced Solid Malignancies</brief_title>
	<detailed_description />
	<criteria>Diagnosis metastatic cancer progress currently available therapy ; At least 3 month life expectancy ; Primary cancer must solid ( nonhematologic ) ; Adequate bone marrow , liver &amp; kidney function ; Negative pregnancy test . Serious , uncontrolled medical disorder ; Individuals willing able use acceptable method avoid pregnancy entire study period least 3 month study ; Pregnant breastfeed woman ; Patients know brain metastasis ; Uncontrolled significant cardiovascular disease ; Anticancer therapy within 26 week prior study drug ( depend therapy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Solid tumor</keyword>
	<keyword>cancer</keyword>
	<keyword>HER-2-expressing tumor</keyword>
</DOC>